StockWatch
·

Adroit Industries (India) Ltd Q2 FY27 Results

ADROITINDQ2 FY27 Results
Filing
Result:Steady· Market: Down#Margin expansion

Outlook: Optimistic · Guidance: None

MetricValue (₹ Cr)vs Q1 FY27
Revenue42.6725.1%
Total Income43.7923.7%
Expenditure33.1928.3%
PBT10.6011.2%
Net Profit8.5514.1%
OPM28.02%
NPM19.52%1.63pp
EPS1.9111.2%
View full financials

Auto-ancillary core profitability (NPM ~19.5%, OPM ~28%) looks healthy but with no YoY comparison available to confirm growth versus the sector, this reads as in-line rather than a confirmed standout.

ADROIT INDUSTRIES · Q2 FY27 · THE VERDICT

Sequential Strength, But the ₹250 Crore Question Looms

Q2 delivered strong 25% sequential revenue growth and margins hit the target band. But management's FY28 forecast—₹250 crore, or 62% growth—leans heavily on new segments still in testing. The street's 35% drawdown from highs suggests it's pricing in that execution risk.

31 Oct 2026 · 6 min read
Q2 Revenue

₹42.7 Cr

+25.1% QoQ; annualized ₹171 Cr

H1 FY27 Run-Rate

₹154 Cr

annualized from ₹76.8 Cr actual

FY28 Target

₹250 Cr

requires 62% growth; new segments unproven

EBITDA Margin

28.0%

H1 at 29.3%; target 30% ±2pp

The earnings print is solid: Q2 revenue hit ₹42.7 crore (+25.1% QoQ), PAT rose to ₹8.5 crore (+14.1% QoQ), and EBITDA margin sits at 28%, well within the management's 30% ±2 percentage point guidance band. The delivered results validate what management said on the call. But beneath that operational strength sits an unresolved question: can the company actually grow from a current run-rate of ₹154 crore (H1 annualized) to ₹250 crore in FY28—a 62% leap—when the incremental revenue depends on industrial and defence shafts that are still in 6–12 month testing cycles?

What the numbers say

Q2 shows sequential momentum intact. Revenue ₹42.7 crore vs. Q1's ₹34.14 crore = 25.1% growth. PAT ₹8.5 crore vs. Q1's ₹7.46 crore = 14.1% growth. EBITDA margin stands at 28%, with H1 average at 29.3%—both comfortably in the targeted 28–32% band. The order book is ₹68–70 crore, representing roughly 1.5 times the FY27 full-year guidance (>₹180 crore), and 78% export-weighted, supporting near-term visibility. But the H1 run-rate of ₹154 crore annualized leaves a ₹96 crore gap to the FY28 target. That gap is the full ₹250 crore story—and it rests on two unproven pieces.

Management's claims vs. Q2 delivery

Q2 revenue grew 25% sequentially

₹42.67 Cr vs ₹34.14 Cr Q1 = 25.1% QoQ

Supported

PAT increased 14% sequentially

₹8.5 Cr vs ₹7.46 Cr Q1 = 14.1% QoQ

Supported

EBITDA margin ~30% going forward

Q2 at 28%, H1 at 29.3%; both in 30% ±2pp band

Supported

Revenue targeting ~₹250 Cr FY28

Annualized H1 run-rate is ₹154 Cr; target requires 62% growth

Overstated (dependent on unproven new segments)

What changed on this call

  • Capacity roadmap crystallized: Pithampur 900k → 1.8M units by Q4 FY27; Dewas 3k → 5.5k tonnes by Q1 FY28

  • Order book disclosed: ₹68–70 crore (78% export, 22% domestic)

  • New-segment timelines specific: Industrial shafts ramp FY28; defence still in 6–12 month testing

  • Universal joints in-house by Nov 2026 targeted for margin uplift

The bull-bear ledger

  • Strong sequential growth (25% revenue, 14% PAT) and margin expansion (22% FY26 → 28% Q2)

  • Repeat customer base solid at 87.4%; 13 new customers added Q2 (organic expansion)

  • Order book at 1.5× FY27 guidance, supporting near-term revenue visibility

  • Capacity expansion on schedule (equipment ₹50 Cr purchased, ₹30 Cr more on order)

  • FY28 target (₹250 Cr = 62% growth) contingent on industrial & defence shafts exiting testing phase

  • Export concentration at 82.4% (H1 FY27), US exposure 59.6% of exports; geopolitical/macro risk

  • Working capital cycle at 248–249 days; improvement to 200–230 days not yet realized

  • Global competitors (Dana, Spyker, Cummins, Neapco) entrenched; pricing power unproven at scale

Risks, ranked by how much they should concern a holder

Key execution and market risks

New-segment revenue timing

High

Industrial and defence shafts in 6–12 month testing. Delays would derail ₹250 Cr FY28 target and require aggressive catch-up.

Export concentration & US exposure

Medium

82.4% of H1 revenue from exports, 59.6% of exports to US. Tariffs, trade friction, or US macro slowdown pose material revenue risk.

Working capital intensity at scale

Medium

Current cycle 248–249 days. Growth to ₹250 Cr FY28 requires incremental WC and capex; improvement to 200–230 days not yet achieved.

Capacity ramp execution

Medium

Pithampur and Dewas expansions (Q4 FY27, Q1 FY28) critical to FY28 target. Installation delays would crimp near-term upside.

Competitive intensity

Medium

Global leaders (Dana, Spyker, Cummins, Neapco) entrenched. Pricing power and customer stickiness unproven at Adroit's anticipated scale.

How the street is reading it

The stock announced results on 12 October 2026 at ₹193.8 (pre-result close) and fell 4.82% on day 1, fading to −1.16% by day 3. The initial sell-off was sharp but did not hold—a sign the market absorbed the numbers without panic. However, the stock is now trading at ₹167.65, down 35.47% from its all-time high of ₹259.8 and only 11.03% above its 52-week low of ₹151. Trading below its 20-day SMA of ₹187.67 with RSI at 28.9 (oversold), and volume decreasing, the stock is showing exhaustion sellers rather than conviction.

Bulk deal activity over the past six months shows mixed institutional flows—PRIJAL TRADEFIN and SETU SECURITIES alternating buys and sells in similar magnitudes—with no evidence of sustained insider or promoter selling near the highs. This suggests the drawdown reflects fundamental skepticism about the FY28 growth narrative rather than insider dumping. The 35% drawdown from ATH, coupled with oversold RSI and decreasing volume, could signal a capitulation low—but only if the next quarter confirms capacity expansion and new-segment momentum are real.

What to watch next
  • 1 · H2 FY27 run-rate & FY27 full-year result

    Management targets >₹180 Cr FY27 full-year. H1 ₹76.8 Cr means H2 must deliver ₹103.2+ Cr (34% sequential growth). If H2 merely repeats H1 pace or decelerates, the >₹180 Cr target is missed and FY28 credibility sinks.

  • 2 · Capacity commissioning timeline (Q4 FY27, Q1 FY28)

    Pithampur doubling (900k → 1.8M units) and Dewas ramp (3k → 5.5k tonnes) are the foundation of 62% FY28 growth. Any delay signals ₹250 Cr is at risk.

  • 3 · Industrial & defence revenue traction

    By Q3/Q4 FY27, look for evidence that shafts are exiting testing phase and generating material revenue. Silence or delays here would confirm the FY28 target is overstated.

Adroit delivered a solid Q2: sequential growth is real, margins are in band, and the order book supports near-term revenue. The operational story is not broken. But the ₹250 crore FY28 target—central to the bull case—is contingent, not certain. New segments in testing, export concentration, and working capital intensity are all real headwinds. The street's 35% drawdown from highs prices in real execution risk, and rightly so.

The number to track from here is simple: H2 FY27 run-rate. If sequential momentum holds (or accelerates toward that >₹180 Cr full-year target), the near-term thesis is intact. If H2 disappoints—staying flat or declining—then the FY28 story is much harder to believe, and the stock has further to fall. The capacity ramps (Q4, Q1) and early industrial/defence revenue pulls are the next two credibility tests. For now, the call is steady execution, not a step-change; show, don't tell.

Informational and educational content only. Not investment advice.